Parallel Advisors’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2K Sell
1,288
-162
-11% -$1.74K ﹤0.01% 2637
2026
Q1
$12.3K Buy
1,450
+315
+28% +$3.45K ﹤0.01% 2662
2025
Q4
$12.8K Sell
1,135
-839
-43% -$10.4K ﹤0.01% 2505
2025
Q3
$29.6K Buy
1,974
+680
+53% +$9.9K ﹤0.01% 2066
2025
Q2
$18.3K Sell
1,294
-66
-5% -$1.18K ﹤0.01% 2244
2025
Q1
$32.7K Buy
1,360
+1,036
+320% +$36.5K ﹤0.01% 1885
2024
Q4
$12.1K Sell
324
-8
-2% -$373 ﹤0.01% 2352
2024
Q3
$16.6K Sell
332
-10
-3% -$389 ﹤0.01% 2191
2024
Q2
$11.9K Buy
342
+33
+11% +$1.3K ﹤0.01% 2241
2024
Q1
$16.9K Sell
309
-5
-2% -$248 ﹤0.01% 2065
2023
Q4
$13.4K Buy
314
+303
+2,755% +$9.42K ﹤0.01% 2155
2023
Q3
$286 Hold
11
﹤0.01% 3192
2023
Q2
$263 Hold
11
﹤0.01% 3210
2023
Q1
$150 Sell
11
-10
-48% -$159 ﹤0.01% 3304
2022
Q4
$291 Buy
+21
New +$297 ﹤0.01% 3129

Other funds holding BHVN

Parallel Advisors's BHVN Position: Q2 2026 in Review

Parallel Advisors reduced its Biohaven (BHVN) stake by 11% in Q2 2026, selling an estimated $1.74K and leaving 1,288 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

Parallel Advisors first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $32.7K in Q1 2025. 105 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Parallel Advisors held 1,288 shares of Biohaven worth $19.2K as of Q2 2026.
  • Parallel Advisors sold 162 Biohaven shares in Q2 2026, an estimated $1.74K.
  • Biohaven made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2637 holding.
  • Parallel Advisors first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Parallel Advisors's Biohaven position peaked at $32.7K in Q1 2025.
  • 105 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.